Blue light phototherapy for Grover's Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Grover's Disease+1 MoreBlue light phototherapy - Device
Eligibility
18 - 89
All Sexes
What conditions do you have?
Select

Study Summary

This trial will see if blue-light therapy can improve symptoms in patients with psoriasis or Grover's Disease.

Eligible Conditions
  • Grover's Disease
  • Plaque Psoriasis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 1 Secondary · Reporting Duration: Time Frame: 1 year

Time Frame: 1 year
Assess user experience
Cellular analysis of Blue light phototherapy
Efficacy of blue light therapy for patients with Grover's disease or psoriasis vulgaris
Efficacy of blue light therapy for patients with psoriasis vulgaris

Trial Safety

Trial Design

1 Treatment Group

Adult treatment arm
1 of 1

Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Blue light phototherapy · No Placebo Group · N/A

Adult treatment arm
Device
Experimental Group · 1 Intervention: Blue light phototherapy · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: time frame: 1 year

Who is running the clinical trial?

T-Cellerate LLCUNKNOWN
Northwestern UniversityLead Sponsor
1,458 Previous Clinical Trials
790,065 Total Patients Enrolled
Shuai XuPrincipal InvestigatorNorthwestern University
6 Previous Clinical Trials
325 Total Patients Enrolled

Eligibility Criteria

Age 18 - 89 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: